Close

Isis Pharma (ISIS) Tops Q3 EPS by 1c

November 9, 2015 9:20 AM EST

Isis Pharma (NASDAQ: ISIS) reported Q3 EPS of ($0.30), $0.01 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $49.1 million versus the consensus estimate of $52.93 million.

For earnings history and earnings-related data on Isis Pharma (ISIS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings